⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Godavari Biorefineries LimitedGODAVARIB

Godavari Biorefineries Limited is a leading manufacturer of chemicals, pharmaceuticals, and food products in India. The company operates primarily through its manufacturing and trading businesses.

Key productsPharmaceuticals, Food Products, Chemicals
GeographyIndia
CompetitorsGrasim Industries, Reliance Industries, Hindustan National Glass, IOL Chemicals & Pharmaceuticals

AI-generated overview β€” verify before relying on it.

Net institutional flow

βˆ’β‚Ή27.1 Cr

Institutional buyers

0 in / 3 out

High-impact filings

0 Β· tilt Neutral

Next corporate action

β€”

Competitive landscape β€” the read

vs most-traded names Β· 6M
Institutional money is backing ATALREAL hardest (+β‚Ή7.2 Cr net). GODAVARIB ranks #4 of 7 on flow (net buying +β‚Ή0 Cr).
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+β‚Ή7.2 Cr157β€”β€”β€”β€”
2QUADFUTURE+β‚Ή0.1 Cr148β€”β€”β€”β€”
3MOBIKWIK+β‚Ή0.1 Cr83β€”β€”β€”β€”
4GODAVARIBThis+β‚Ή0 Cr2β€”β€”β€”β€”
5MTNL+β‚Ή0 Cr2β€”β€”β€”β€”
6GATECH+β‚Ή0 Cr8β€”β€”β€”β€”
7IRMENERGYβˆ’β‚Ή2.2 Cr328β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” GODAVARIB day by day

  1. 2026-06-16FilingGodavari Biorefineries Limited has informed the Exchange about Japanese Patent Office granted our patent, "5-HGeneral
  2. 2026-02-27BulkBUY Β· β‚Ή8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  3. 2026-02-27BulkSELL Β· β‚Ή8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  4. 2026-02-27NetDay net βˆ’β‚Ή0 Cr

Merged from deals, filings, corporate actions and news β€” newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 2
    GeneralNeutral

    Japanese Patent Office granted our patent, "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER

    Source PDF β†’

Bulk & block deals

2 deals Β· 2026-02-27 β†’ 2026-02-27

DateCounterpartyTypeSideValue
2026-02-27NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUYβ‚Ή8.5 Cr
2026-02-27NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELLβ‚Ή8.5 Cr

2 deals in the selected window β€” corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on GODAVARIB

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.